Analyst Ratings for Supernus Pharmaceuticals Inc. (SUPN)

Updated: 2017-07-27

An average rating of Overweight has been given to Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by analysts covering the stock. SUPN had previously received a consensus rating of Buy a month ago.

Of the 7 analysts covering the stock, 5 gave it a buy rating, 0 issued an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for SUPN. The highest price target was 51, which equates to a potential upside of 24.09 percent. The most pessimistic analyst gave a price target of 40, implying potential capital losses of -2.68 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -7.56 percent. The average change in earnings estimates over the last 90 days is -23.79 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -7.71 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -21.32 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 3 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 3 analysts made negative revisions to their fiscal year's estimates.

The growth rate of SUPN's earnings is estimated by analysts to be -46.43 percent. The PEG ratio of a stock is another value frequently studied by investors. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. SUPN has a PEG ratio of -0.48.

In the last 52-weeks, SUPN has achieved a high of 44.95 and a low of 17.25. Currently the stock is 138.26 percent higher than its low, and 8.57 percent lower than its 52-week high. SUPN has a price/earnings ratio of 22.48. Investors typically compare the P/E ratio to a company's peers in the industry. The SUPN value stock report compares SUPN to some of its peers using value stock charts. The market cap of SUPN is $2.12 billion. SUPN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.